Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carbetocin vs Oxytocin + Misoprostol for C-Section Blood Loss
NCT05664659Phase 4Completed
- Sponsor
- Ain Shams University Maternity Hospital
- Start
- Dec 2022
- Primary completion
- Apr 2023
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of carbetocin in postpartum hemorrhage (PPH) (2 arms), sponsored by Ain Shams University Maternity Hospital. Primary endpoint: estimated blood loss. Started Dec 2022; status: completed.
02
Drugs
carbetocin
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on NCT05664659.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05664659.